Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JGOG3020 ECO trial of adjuvant chemotherapy versus observation in stage I epithelial ovarian cancer
jRCTs031180423Phase 3Active, not recruiting
- Start
- Jul 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of paclitaxel, docetaxel and carboplatin in epithelial ovarian cancer (EOC) (2 arms). Primary endpoint: Disease-specific survival. Started Jul 2012; status: active, not recruiting.
02
Drugs
paclitaxeldocetaxelcarboplatin
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on jRCTs031180423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180423.